Derriford Research Facility
Plymouth University is building a prestigious £17 million facility to provide a research-intensive environment to investigate cancer; infection, immunity and inflammation; & neurodegenerative diseases, including:
Brain tumours, dementia, Parkinson’s, Huntington’s, antibiotic resistance, oral cancer, non-Hodgkins lymphoma, Ebola and bovine tuberculosis.
Thousands affected by devastating diseases
Too many diseases have no cure, such as brain tumours, dementia, and Parkinson’s disease.
Currently, there are 850,000 people with dementia in the UK, and around 127,000 people living with Parkinson's with another person is diagnosed every hour. Brain tumours are the biggest cancer killer of children and the under-40 with brain cancer deaths rising; unlike other forms of cancers.
Plymouth University has a growing body of world-leading scientists undertaking cutting-edge research in health and medicine. However, their current dispersion across three sites impacts their collaborative efficiency and access to equipment.
Accelerating research towards a cure
Due for completion in July 2017, the £17m Derriford Research Facility (DRF) will bring together our expert teams and clinicians. The new space and hi-tech equipment will accelerate our world-leading research ever-closer to finding treatments, cures, and vaccines against some of the biggest health issues faced today.
The facility is purposefully placed between our existing Plymouth University Peninsula Schools of Medicine and Dentistry, and Derriford Hospital to create powerful collaborations between our research teams, clinicians, and the pharmaceutical and biotech industries to push discoveries through our 'bench to bedside and back' strategy.
Watch our video about the Derriford Research Facility
Building on our strengths
With leading expertise from around the globe we've made significant headway in many areas of research.
In the UK and we're ranked 1st in the UK for Research Output in Clinical Medicine by the Research Excellence Framework and we are in partnership with the charity Brain Tumour Research, and house a Brain Tumour Research Centre of Excellence.
The DRF will build on these strengths with the potential to attract more of the greatest minds in medicine to Plymouth. Our collaborations and networks will be far reaching and draw the attention of prominent commercial partners to fast-track our research into clinical trials.
We need your support
Building this DRF demonstrates our commitment to growing world-leading research.
We need your help to raise £1.5 million to grow our teams with PhD studentships, and to purchase vital equipment to push our pioneering research forward.
A key factor is the provision of modern state of the art facilities. Unfortunately, most grants, even from prestigious national bodies, do not cover these critical areas. Although Plymouth is a ‘young’ medical school and our teams are doing outstanding work with what they already have, we desperately need to expand that infrastructure if they are to thrive.
Press office news
- Funders need to take more responsibility for the efficiency of the research they fund 9 March 2017
- Plymouth dementia scientist bound for Vienna conference 2 March 2017
- Minute’s silence marks the start of Brain Tumour Awareness Month 1 March 2017
- Funds raised for world-leading Huntington’s disease research 27 February 2017
- Funding for study which could lead to new drug treatment for dementia diseases 24 February 2017